Back to Results
First PageMeta Content
Antibiotics / Glycopeptide antibiotics / Gram-positive bacteria / Pathogenic bacteria / Dalbavancin / Antibiotic resistance / Durata Therapeutics / Quinolone / Clostridium difficile / Bacteria / Biology / Microbiology


A BACTERIAL BATTLE The regulatory path to approving new antibiotics has been cleared, but work still remains to rebuild a HEALTHY DRUG PIPELINE was too toxic,” says Glenn Tillotson, a senior partner at the life science
Add to Reading List

Document Date: 2014-06-12 14:00:02


Open Document

File Size: 931,04 KB

Share Result on Facebook
UPDATE